We are live on ! Find out more
Ulys LLC

Ulys LLC Portfolio holdings

AUM $25.4M Turnover 0%
1-Year Est. Return 201.03%
This Fund
S&P 500
This Quarter Est. Return
-13.26%
1 Year Est. Return
+201.03%
3 Year Est. Return
-31.51%
5 Year Est. Return
-50.88%
10 Year Est. Return
–
AUM
$37M
AUM Growth
-$5.66M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
4.8 years
Top 10 Avg Time Held
4.8 years
Top 20 Avg Time Held
4.8 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LXRX icon
1
Lexicon Pharmaceuticals
LXRX
$681M
$37M 100%
4,321,214
– –
2013 Q2
19 quarters

Similar funds

Ulys LLC's Q1 2018 Portfolio in Review

As of Q1 2018, Ulys LLC held 1 position worth $37M, down 13% from $42.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 0%. Ulys LLC opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ulys LLC's ten largest holdings make up 100% of its $37M portfolio in Q1 2018.
  • Ulys LLC opened 0 new positions and closed 0 in Q1 2018.
  • Ulys LLC's portfolio value fell 13% quarter-over-quarter to $37M.

Based on Ulys LLC's 13F filing for Q1 2018, filed 10 May 2018.